Clinical Trial Update: Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of pembrolizumab plus pelareorep in advanced pancreatic cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer Ajcc V8

Drugs mentioned

• Pelareorep (pelareorep)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Northwestern University | Conditions: Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2021-01-20